Poland
# |
Name |
Price to Sales Ratio (P/S) |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
1,481,732.57 |
Jan. 14, 2025 | USD 2.23 | 1.07% |
|
Poland |
|
2 |
91,280.05 |
Jan. 14, 2025 | USD 1.74 | 1.31% |
|
Poland |
|
3 |
43,209.58 |
Jan. 14, 2025 | USD 0.79 | 1.05% |
|
Poland |
|
4 |
835.38 |
Jan. 14, 2025 | USD 40.10 | -0.57% |
|
Poland |
|
5 |
547.05 |
Jan. 14, 2025 | USD 3.73 | -0.03% |
|
Poland |
|
6 |
209.87 |
Jan. 14, 2025 | USD 1.85 | -0.17% |
|
Poland |
|
7 |
122.11 |
Jan. 14, 2025 | USD 9.29 | -3.28% |
|
Poland |
|
8 |
15.14 |
Jan. 14, 2025 | USD 7.78 | -9.75% |
|
Poland |
|
9 |
14.69 |
Jan. 14, 2025 | USD 10.54 | 0.97% |
|
Poland |
|
10 |
7.87 |
Jan. 14, 2025 | USD 6.09 | -0.44% |
|
Poland |
|
11 |
4.98 |
Jan. 14, 2025 | USD 1.05 | -1.52% |
|
Poland |
|
12 |
4.50 |
Jan. 14, 2025 | USD 1.01 | 1.23% |
|
Poland |
|
13 |
3.89 |
Jan. 14, 2025 | USD 4.27 | -3.25% |
|
Poland |
|
14 |
2.91 |
Jan. 14, 2025 | USD 29.80 | 1.98% |
|
Poland |
|
15 |
2.68 |
Jan. 14, 2025 | USD 50.91 | 0.74% |
|
Poland |
|
16 |
2.32 |
Jan. 14, 2025 | USD 11.11 | -3.75% |
|
Poland |
|
17 |
1.43 |
Jan. 14, 2025 | USD 0.77 | 0.43% |
|
Poland |
|
18 |
1.00 |
Jan. 14, 2025 | USD 12.79 | 0.55% |
|
Poland |
|
19 |
0.98 |
Jan. 14, 2025 | USD 2.34 | 1.69% |
|
Poland |
|
20 |
0.98 |
Jan. 14, 2025 | USD 2.77 | 1.63% |
|
Poland |
|
21 |
0.89 |
Jan. 14, 2025 | USD 4.92 | 2.76% |
|
Poland |
|
22 |
0.67 |
Jan. 14, 2025 | USD 2.77 | 0.74% |
|
Poland |
|
23 |
0.31 |
Jan. 14, 2025 | USD 204.85 | 1.34% |
|
Poland |
The Health Care company in Poland with the highest Price to Sales Ratio (P/S) is Molecure S.A. (Warsaw Stock Exchange: MOC.WA) at 1,481,732.57.
The Health Care company in Poland with the lowest Price to Sales Ratio (P/S) is NEUCA S.A. (Warsaw Stock Exchange: NEU.WA) at 0.31.
The top 10 Health Care companies in Poland by Price to Sales Ratio (P/S) are Molecure S.A., Genomtec S.A., NanoGroup S.A., Scope Fluidics S.A., Pure Biologics Spólka Akcyjna, Medinice S.A., Poltreg S.A., Ryvu Therapeutics S.A., Captor Therapeutics Spolka Akcyjna and Celon Pharma S.A..
The bottom 10 Health Care companies in Poland by Price to Sales Ratio (P/S) are NEUCA S.A., EMC Instytut Medyczny SA, Centrum Medyczne ENEL-MED S.A., BioMaxima S.A., Mabion S.A., Mercator Medical S.A., BIOTON S.A., Selvita S.A., Synektik Spólka Akcyjna and Voxel S.A..